MedPath

Pilot Study of CBT With tDCS for Adults Being Treated for Obsessive Compulsive Disorder

Not Applicable
Withdrawn
Conditions
Obsessive-Compulsive Disorder
Interventions
Device: Sham transcranial direct current stimulation
Device: transcranial direct current stimulation
Registration Number
NCT05964998
Lead Sponsor
Rogers Behavioral Health
Brief Summary

This pilot study aims to compare the effect of transcranial direct current stimulation (tDCS) versus sham stimulation, delivered immediately prior to cognitive-behavioral therapy (CBT) for obsessive-compulsive disorder (OCD), on patient-reported outcomes. The investigator hypothesize that patients who receive active stimulation will experience greater improvement in OCD symptoms than those who receive sham stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Primary diagnosis of Obsessive-Compulsive Disorder (OCD)
  • Resident of state of Wisconsin
  • Enrolled in OCD Intensive Outpatient Program (IOP) at Rogers Behavioral Health in Oconomowoc, WI
  • Ability to communicate effectively using written and spoken English
Exclusion Criteria
  • Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
  • Currently taking medication that reduces seizure threshold (e.g., clomipramine)
  • Cranial pathologies (e.g., holes, plates)
  • History of seizure or black-out concussion
  • Pregnancy
  • Previous treatment at Rogers Behavioral Health

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham stimulationSham transcranial direct current stimulation-
Active stimulationtranscranial direct current stimulation-
Primary Outcome Measures
NameTimeMethod
Change in Quick Inventory of Depressive Symptomology from admission to dischargeUp to 12 weeks
Change in Yale-Brown Obsessive-Compulsive Scale - Self-Report from admission to dischargeUp to 12 weeks
Secondary Outcome Measures
NameTimeMethod
Change in Quality of life enjoyment and satisfaction questionnaire - short form from admission to dischargeUp to 12 weeks
Change in Subjective units of distress from admission to dischargeUp to 12 weeks
Change in Obsessive-Compulsive Inventory-Revised from admission to dischargeUp to 12 weeks
Number of treatment days between admission and dischargeUp to 12 weeks
Change in Intolerance of uncertainty scale from admission to dischargeUp to 12 weeks

Trial Locations

Locations (1)

Rogers Behavioral Health

🇺🇸

Oconomowoc, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath